Search
for
Sort by
Research 301–330 of 488
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Study of the Thyroid Profile of Patients with Alopecia
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- 042 Characterization of Pathogenic CD8+ T Cells in an adoptive transfer Mouse Model of Alopecia Areata in C3H/HeJ mice
- 039 Expansion of regulatory T Cells restrains pathogenic CD8 T Cells in a murine model of alopecia areata
- 058 Subset analysis of NKG2D+ cells in peripheral blood mononuclear cells
- Generation of autoreactive CD8 T cell in a mouse model of alopecia areata
- The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model
- The immunopathogenesis of Alopecia Areata
- Prior antigen experience influences the development of alopecia areata in C3H/HeJ mice 2258436
- CD4+ Treg expansion arrests disease progression in a pre-clinical model of alopecia areata
- The investigation of selective sphingosine-1 phosphate receptor 1&4 modulator to treat alopecia areata mouse model 2881
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- 006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice
- Exogenous IL-27 prevents the development of alopecia areata
- 26 Characterization of a murine model of aa induced by adoptive transfer of cultured lymph node cells
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- 058 The pattern of Fas and Fas ligand expression in alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Mathematical model for alopecia areata
- Advance Understanding and New Treatment of Alopecia Areata
- 396 Vδ1 + T-cells are stress-sentinels in human skin and are implicated in alopecia areata pathogenesis